Lupin gets tentative U.S. FDA approval for Enzalutamide tablets in four strengths

The generic drug application covers 40 mg, 80 mg, 120 mg, and 160 mg tablets, with Lupin saying the added strengths could expand dosing options beyond Astellas' Xtandi tablets.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.